Plasma AGE - peptides and C - peptide in <font color="blue">early_4</font> <font color="blue">-_4</font> <font color="blue">stage_4</font> <font color="blue">diabetic_5</font> <font color="blue">nephropathy_5</font> <font color="blue">patients_5</font> <font color="blue">on_2</font> <font color="blue">thiamine_2</font> <font color="blue">and_2</font> <font color="blue">pyridoxine_2</font> <font color="blue">therapy_2</font> <font color="blue">._2</font> 
<br>
<br> AIM The aim of the study was to evaluate circulatory AGE - peptide levels in diabetic nephropathy and to observe the effects of thiamine ( vitamin B1 ) and pyridoxine ( vitamin B6 ) therapy . 
<br> METHODS <font color="blue">Type_5</font> <font color="blue">2_5</font> <font color="blue">diabetic_5</font> <font color="blue">patients_5</font> <font color="blue">(_4</font> <font color="blue">N.=57_4</font> <font color="blue">)_4</font> were divided into two groups as " with nephropathy " ( N.=27 ) and " without nephropathy " ( N.=30 ) . <font color="blue">Diabetic_3</font> <font color="blue">nephropathy_3</font> <font color="blue">patients_3</font> were treated with either B6 ( N.=12 ) ( 250 mg / day ) or B1+B6 ( N.=15 ) ( 250 mg / day , each ) for five months . At the beginning and the end of the experimentation period , glucose , HbA1c , triglyceride , cholesterol , insulin , C - peptide , thiamine pyrophosphate , pyridoxal phosphate and AGE- peptides were measured . 
<br> RESULTS AGE - peptides were higher in the <font color="blue">diabetic_2</font> <font color="blue">group_2</font> <font color="blue">with_1</font> <font color="blue">nephropathy_1</font> than without nephropathy ( P=0.005 ) . Within five months AGE - peptides increased in the <font color="blue">diabetic_2</font> <font color="blue">group_2</font> <font color="blue">without_2</font> <font color="blue">nephropathy_2</font> <font color="blue">(_1</font> <font color="blue">P=0.042_1</font> <font color="blue">)_1</font> but not in the <font color="blue">group_1</font> <font color="blue">with_1</font> <font color="blue">nephropathy_1</font> treated either with B1+B6 or B6 . In B6 treated group a substantial decrease was observed in HbA1c ( P=0.033 ) . B1+B6 or B6 treatment both caused an increase in C - peptide ( P=0.006 , P=0.004 ) . 
<br> CONCLUSION Among the parameters measured , plasma AGE - peptides was the only parameter found to be higher in <font color="blue">type_3</font> <font color="blue">2_3</font> <font color="blue">diabetes_3</font> <font color="blue">mellitus_3</font> <font color="blue">patients_3</font> <font color="blue">"_1</font> <font color="blue">with_1</font> <font color="blue">nephropathy_1</font> <font color="blue">"_1</font> than " without nephropathy " . However , <font color="blue">patients_2</font> <font color="blue">with_1</font> <font color="blue">nephropathy_1</font> <font color="blue">treated_1</font> <font color="blue">with_1</font> <font color="blue">B1+B6_1</font> <font color="blue">or_1</font> <font color="blue">B6_1</font> did not display any further increase in AGE - peptides within five months . Both of the treatments caused an increase in C - peptide .